{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/ovarian-cancer/diagnosis/when-to-suspect-ovarian-cancer/","result":{"pageContext":{"chapter":{"id":"26a540a4-c12b-5ae8-b3de-eb2d3472a824","slug":"when-to-suspect-ovarian-cancer","fullItemName":"When to suspect ovarian cancer","depth":2,"htmlHeader":"<!-- begin field 237799b3-a50b-44e9-add9-8b755134bec8 --><h2>When should I suspect ovarian cancer?</h2><!-- end field 237799b3-a50b-44e9-add9-8b755134bec8 -->","summary":"","htmlStringContent":"<!-- begin item f7ee88cd-6aa4-42e1-a1a3-d15c3f661a27 --><!-- begin field c3e0b521-57d2-4169-a338-28550139867b --><ul><li><strong>Suspect ovarian cancer and carry out <a class=\"topic-reference internal-reference\" href=\"/topics/ovarian-cancer/management/managing-a-woman-with-suspected-ovarian-cancer/#management\">tests</a>:</strong><ul><li>In any woman (particularly if over 50 years of age) if any of the following symptoms are persistent or frequent (particularly more than 12 times per month):<ul><li>Abdominal distension (bloating).</li><li>Feeling full (early satiety) and/or loss of appetite.</li><li>Pelvic or abdominal pain.</li><li>Increased urinary urgency and/or frequency.</li></ul></li><li>In any woman over 50 years of age, if she has had:<ul><li>Symptoms suggestive of irritable bowel syndrome (IBS) within the last 12 months. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/irritable-bowel-syndrome/\">Irritable bowel syndrome</a> for more information.</li></ul></li></ul></li><li><strong>Consider the possibility of ovarian cancer and consider carrying out <a class=\"topic-reference internal-reference\" href=\"/topics/ovarian-cancer/management/managing-a-woman-with-suspected-ovarian-cancer/#management\">tests</a> in any woman who reports any of the following <em>unexplained</em> symptoms:</strong><ul><li>Weight loss.</li><li>Malaise or fatigue.</li><li>Change in bowel habit.</li></ul></li><li><strong>Other symptoms of ovarian cancer that may be present include:</strong><ul><li>Abnormal or postmenopausal bleeding.</li><li>Gastrointestinal symptoms, such as dyspepsia, nausea, or bowel obstruction.</li><li>Shortness of breath (due to pleural effusion).</li></ul></li></ul><!-- end field c3e0b521-57d2-4169-a338-28550139867b --><!-- end item f7ee88cd-6aa4-42e1-a1a3-d15c3f661a27 -->","topic":{"id":"e76d1533-c4e4-5615-b47d-b9a78e802a8c","topicId":"2b5f9995-52a6-4997-b11b-4dd86f5b4cac","topicName":"Ovarian cancer","slug":"ovarian-cancer","lastRevised":"Last revised in July 2018","chapters":[{"id":"00f52bf3-2854-5c26-896d-9e19a7a50ffa","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"1978d14c-1832-5012-aad2-ae688f64a4f0","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"39ed13eb-bf02-5897-9546-f63bb13e1312","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"b6205ec5-8fed-5fa0-9459-17c9ed9797a4","slug":"changes","fullItemName":"Changes"},{"id":"dff67d8b-2740-5711-b49a-d03a83243ab3","slug":"update","fullItemName":"Update"}]},{"id":"4d027c28-c2b3-5578-8eab-c2029d5b3347","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"f40d2697-554a-5249-abb4-6247e9db5eca","slug":"goals","fullItemName":"Goals"},{"id":"6b3fba32-56cd-5102-879a-64cb859b80ef","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"8e5550d6-e4d8-54a5-8046-0542cdf4be38","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"c7811d8a-c44d-5470-8e72-e0a8ff4d2d61","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"816a9080-6571-5a58-bfe1-04411127e3d2","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"4afe1f86-c28e-51bf-8c7f-39373606165d","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"39f05ca6-5cf0-5e67-af39-03983de815d1","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"03b4909c-fc38-5af3-848f-1df54131e0c5","slug":"definition","fullItemName":"Definition"},{"id":"83553e71-1f1a-543b-be50-09b4c7b8c224","slug":"incidence","fullItemName":"Incidence"},{"id":"c8597bdc-f028-5141-85c3-c6b429bf7d78","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"e5f859f0-168b-5395-a133-af2778a0ef84","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"4d5f7685-3efd-5198-90e1-d8cb8f470a28","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"26a540a4-c12b-5ae8-b3de-eb2d3472a824","slug":"when-to-suspect-ovarian-cancer","fullItemName":"When to suspect ovarian cancer"},{"id":"d7d39f7a-9f30-588c-9589-b8c8b5a76729","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"d02788d8-8b2d-5672-8eca-dfcc643a2055","fullItemName":"Management","slug":"management","subChapters":[{"id":"e47609d5-133b-5929-ad56-44ab30116871","slug":"managing-a-woman-with-suspected-ovarian-cancer","fullItemName":"Scenario: Managing a woman with suspected ovarian cancer"}]},{"id":"99dcdee4-9931-5ef8-a3d8-d86417646b02","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"9b4bd4c6-cb71-5783-8529-7346c25fc30f","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"11ba9663-4a8b-516e-a825-1f8d766c7041","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"ec67bf69-9ccc-5c53-81da-f2c0713d4527","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"bcf5ab6b-23af-5b9a-bbcd-22d0002e20cf","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"ac95df2b-f68f-5f64-bb51-88ff094f74b8","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"23bfe348-903c-5728-b9b9-71e7975e7e53","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"faaa4aff-4567-544b-af9e-b7dc24fae5df","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"4d5f7685-3efd-5198-90e1-d8cb8f470a28","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"6f1c98e8-a53f-5039-9fb0-582bae5c9dea","slug":"basis-for-recommendation-7a9","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field cf3a31aa-1283-4262-be18-97e7116417e7 --><h3>Basis for recommendation</h3><!-- end field cf3a31aa-1283-4262-be18-97e7116417e7 -->","summary":null,"htmlStringContent":"<!-- begin item 7a94fd52-a44a-4362-9133-32a2742d1797 --><!-- begin field 2b719537-18ab-4a25-908e-ae63cc91099e --><h4>Symptoms associated with ovarian cancer</h4><ul><li>Recommendations on when to suspect ovarian cancer are based on evidence identified by the National Institute for Health and Clinical Excellence (NICE) in the guideline <em>Ovarian cancer: the recognition and initial management of ovarian cancer </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/ovarian-cancer/references/\">National Collaborating Centre for Cancer, 2011</a>].<ul><li>A systematic review estimated that 93% of women with ovarian cancer experienced symptoms prior to diagnosis (95% CI 0.92 to 0.94).</li><li>Evidence from retrospective case control studies showed that abdominal pain, abdominal distension, urinary symptoms, abdominal mass, and postmenopausal/abnormal bleeding are more likely to be reported by women before a diagnosis of ovarian cancer than in women without ovarian cancer.</li><li>The following individual symptoms for ovarian cancer where reported, assuming a prior probability of undiagnosed ovarian cancer of 0.04%:<ul><li>Abdominal pain (sensitivity 17–64%; specificity 70–95%).</li><li>Abdominal bloating (sensitivity 5–68%; specificity 62–98%).</li><li>Abdominal distension (sensitivity 22–86%; specificity 53–99%).</li><li>Abdominal mass/ swelling (sensitivity 16–33%; specificity 99–100%).</li><li>Urinary frequency or urgency (sensitivity 11–43%; specificity 78–97%).</li><li>Abnormal or postmenopausal bleeding (sensitivity 13–20%; specificity 96–99%).</li><li>Loss of appetite (sensitivity 14–39%; specificity 70–98%).</li></ul></li></ul></li></ul><h4>Other symptoms associated with ovarian cancer</h4><ul><li>CKS has included abnormal or postmenopausal bleeding as a possible symptom of ovarian cancer. Despite the relatively high sensitivity and specificity of abnormal or postmenopausal bleeding in the diagnosis of ovarian cancer, the NICE guideline development group (GDG) chose not to include this symptom in their recommendations, as abnormal or postmenopausal bleeding alone should trigger an urgent referral for investigations which should identify ovarian cancer<em> </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/ovarian-cancer/references/\">National Collaborating Centre for Cancer, 2011</a>].</li><li>The textbook <em>Clinical Obstetrics and Gynaecology </em>identifies gastrointestinal symptoms (such as dyspepsia, nausea, and bowel obstruction) and breathlessness as possible features of ovarian cancer [<a class=\"bibliography-reference internal-reference\" href=\"/topics/ovarian-cancer/references/\">Crawford, 2009a</a>], although NICE did not identify any evidence for the sensitivity or specificity of these symptoms as predictors of ovarian cancer.</li></ul><!-- end field 2b719537-18ab-4a25-908e-ae63cc91099e --><!-- end item 7a94fd52-a44a-4362-9133-32a2742d1797 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}